In only a decade, the Danish health care product maker Coloplast underwent a major transformation to a really multinational corporation from a local Danish manufacturing company. In 2001, Coloplast ran all its production in-house in three production facilities in Denmark. Ten years later, the firm had relocated nearly 90 per cent of the creation to four different countries, with the bulk in China and Hungary.
However, a transformation of this quality seldom comes without challenges. In this procedure, the firm had experienced many challenges. Although Coloplast had by 2011 successfully identified and changed the critical issues made by the offshoring initiatives, the executive management now faced a considerable challenge in understanding precisely what the business had learned in the last 10 years and how it could shine based on this history.
PUBLICATION DATE: August 02, 2012 PRODUCT #: W12101-PDF-ENG
This is just an excerpt. This case is about STRATEGY & EXECUTION